Surgery for atypical plexiform neurofibromas of the trunk in NF1 with high standardised uptake value (SUV) in positron-emission tomography (PET) expressing podoplanin: a long-term follow-up.

Standard

Surgery for atypical plexiform neurofibromas of the trunk in NF1 with high standardised uptake value (SUV) in positron-emission tomography (PET) expressing podoplanin: a long-term follow-up. / Friedrich, Reinhard; Gawad, Karim; Derlin, Thorsten; Zustin, Jozef; Hagel, Christian.

In: ANTICANCER RES, Vol. 32, No. 10, 10, 01.10.2012, p. 4547-4551.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

APA

Vancouver

Bibtex

@article{f5d8b5ea87394ab1bfb594725c24bc67,
title = "Surgery for atypical plexiform neurofibromas of the trunk in NF1 with high standardised uptake value (SUV) in positron-emission tomography (PET) expressing podoplanin: a long-term follow-up.",
abstract = "A 23-year-old female with an established diagnosis of neurofibromatosis type 1 (NF1) was found to have two tumours in her trunk. These showed high uptake value in positron-emission/computerized tomography (PET) scans, and were suspected to be malignant peripheral nerve sheath tumours (MPNST). The extirpated tumours proved to be atypical plexiform neurofibromas. Slight to moderate podoplanin expression of the tumour cells was noted in areas of fibrillary growth. Six years following surgery, there is neither evidence of local tumour recurrence nor development of MPNST. Current studies on atypical neurofibroma in NF1 suggest podoplanin expression in subtypes of transformed Schwann cells, resembling schwannoma-like areas in neurofibroma. This marker may be useful in distinguishing different Schwann cell populations in NF1.",
keywords = "Humans, Female, Young Adult, Follow-Up Studies, Disease-Free Survival, Positron-Emission Tomography, Tumor Markers, Biological/analysis, Ki-67 Antigen/analysis, Radiopharmaceuticals/diagnostic use, Fluorodeoxyglucose F18/diagnostic use, Membrane Glycoproteins/analysis/biosynthesis, Mucin-1/analysis, Nerve Sheath Neoplasms/chemistry/diagnosis/*surgery, Neurofibroma, Plexiform/chemistry/diagnosis/*surgery, Neurofibromatosis 1/diagnosis/surgery, S100 Proteins/analysis, Humans, Female, Young Adult, Follow-Up Studies, Disease-Free Survival, Positron-Emission Tomography, Tumor Markers, Biological/analysis, Ki-67 Antigen/analysis, Radiopharmaceuticals/diagnostic use, Fluorodeoxyglucose F18/diagnostic use, Membrane Glycoproteins/analysis/biosynthesis, Mucin-1/analysis, Nerve Sheath Neoplasms/chemistry/diagnosis/*surgery, Neurofibroma, Plexiform/chemistry/diagnosis/*surgery, Neurofibromatosis 1/diagnosis/surgery, S100 Proteins/analysis",
author = "Reinhard Friedrich and Karim Gawad and Thorsten Derlin and Jozef Zustin and Christian Hagel",
year = "2012",
month = oct,
day = "1",
language = "English",
volume = "32",
pages = "4547--4551",
journal = "ANTICANCER RES",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "10",

}

RIS

TY - JOUR

T1 - Surgery for atypical plexiform neurofibromas of the trunk in NF1 with high standardised uptake value (SUV) in positron-emission tomography (PET) expressing podoplanin: a long-term follow-up.

AU - Friedrich, Reinhard

AU - Gawad, Karim

AU - Derlin, Thorsten

AU - Zustin, Jozef

AU - Hagel, Christian

PY - 2012/10/1

Y1 - 2012/10/1

N2 - A 23-year-old female with an established diagnosis of neurofibromatosis type 1 (NF1) was found to have two tumours in her trunk. These showed high uptake value in positron-emission/computerized tomography (PET) scans, and were suspected to be malignant peripheral nerve sheath tumours (MPNST). The extirpated tumours proved to be atypical plexiform neurofibromas. Slight to moderate podoplanin expression of the tumour cells was noted in areas of fibrillary growth. Six years following surgery, there is neither evidence of local tumour recurrence nor development of MPNST. Current studies on atypical neurofibroma in NF1 suggest podoplanin expression in subtypes of transformed Schwann cells, resembling schwannoma-like areas in neurofibroma. This marker may be useful in distinguishing different Schwann cell populations in NF1.

AB - A 23-year-old female with an established diagnosis of neurofibromatosis type 1 (NF1) was found to have two tumours in her trunk. These showed high uptake value in positron-emission/computerized tomography (PET) scans, and were suspected to be malignant peripheral nerve sheath tumours (MPNST). The extirpated tumours proved to be atypical plexiform neurofibromas. Slight to moderate podoplanin expression of the tumour cells was noted in areas of fibrillary growth. Six years following surgery, there is neither evidence of local tumour recurrence nor development of MPNST. Current studies on atypical neurofibroma in NF1 suggest podoplanin expression in subtypes of transformed Schwann cells, resembling schwannoma-like areas in neurofibroma. This marker may be useful in distinguishing different Schwann cell populations in NF1.

KW - Humans

KW - Female

KW - Young Adult

KW - Follow-Up Studies

KW - Disease-Free Survival

KW - Positron-Emission Tomography

KW - Tumor Markers, Biological/analysis

KW - Ki-67 Antigen/analysis

KW - Radiopharmaceuticals/diagnostic use

KW - Fluorodeoxyglucose F18/diagnostic use

KW - Membrane Glycoproteins/analysis/biosynthesis

KW - Mucin-1/analysis

KW - Nerve Sheath Neoplasms/chemistry/diagnosis/surgery

KW - Neurofibroma, Plexiform/chemistry/diagnosis/surgery

KW - Neurofibromatosis 1/diagnosis/surgery

KW - S100 Proteins/analysis

KW - Humans

KW - Female

KW - Young Adult

KW - Follow-Up Studies

KW - Disease-Free Survival

KW - Positron-Emission Tomography

KW - Tumor Markers, Biological/analysis

KW - Ki-67 Antigen/analysis

KW - Radiopharmaceuticals/diagnostic use

KW - Fluorodeoxyglucose F18/diagnostic use

KW - Membrane Glycoproteins/analysis/biosynthesis

KW - Mucin-1/analysis

KW - Nerve Sheath Neoplasms/chemistry/diagnosis/surgery

KW - Neurofibroma, Plexiform/chemistry/diagnosis/surgery

KW - Neurofibromatosis 1/diagnosis/surgery

KW - S100 Proteins/analysis

M3 - SCORING: Journal article

C2 - 23060584

VL - 32

SP - 4547

EP - 4551

JO - ANTICANCER RES

JF - ANTICANCER RES

SN - 0250-7005

IS - 10

M1 - 10

ER -